Friday, April 24, 2020 - 16:30

Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the filing of its 2019 Universal Registration Document (Document d’enregistrement universel) for the year ended December 31, 2019 with the French market authority “Autorité des Marchés Financiers” (“AMF”). It can be consulted and downloaded (in French) on the Company’s website (https://investors.innate-pharma.com/regulated-information/financial-reports) and on the AMF’s website (www.amf-france.org).

The Company also announced today the filing of its annual report on Form 20-F for the year ended December 31, 2019 with the United States Securities and Exchange Commission (“SEC”). It can be consulted and downloaded on the Company’s website (https://investors.innate-pharma.com/regulated-information/financial-reports) and on the SEC’s website (www.sec.gov).

AttachmentSize
CP en français112.04 KB
PR in English135.48 KB
Document d'enregistrement universel 20197.62 MB
Form 20-F2.46 MB